See also this year's filing and all EDGAR filings for this company.
PDF Report 0001404644_2023_Neoleukin_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001404644, Neoleukin Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 99,134,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 16,814,000 |
| 4 | LiabilitiesCurrent | 11,062,000 |
| 5 | LiabilitiesNoncurrent | 10,322,000 |
| 6 | remainder_Liabilities | 233,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 17,968,000 |
| 9 | ResearchAndDevelopmentExpense | 41,129,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,540,000 |
| 13 | remainder_ComprehensiveNetIncome | -21,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 115,948,000 |
| 1 | Liabilities | 21,617,000 |
| 2 | Expenses | 59,097,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 94,331,000 |
| 5 | NetIncome | -57,557,000 |
| 6 | ComprehensiveNetIncome | -57,567,500 |
| 7 | BaseVar | 99,111,500 |
| 8 | EconomicCapitalRatio | 1.52 |
Edgar->Model Mapping
Feature Distribution
Change over Time
